Wellington Capital Management’s Pfizer PFE Stock Holding History

Wellington Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$442K	Buy	+18,242	New	+$425K	0.66%	61

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Capital Management's PFE Position: Q2 2025 in Review

Wellington Capital Management opened a new position in Pfizer (PFE) in Q2 2025: 18,242 shares worth $442K. The stake represents 0.66% of the portfolio and ranks #61 among its holdings.

2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Wellington Capital Management held 18,242 shares of Pfizer worth $442K as of Q2 2025.
Pfizer was a new Wellington Capital Management position in Q2 2025.
Pfizer made up 0.66% of Wellington Capital Management's portfolio in Q2 2025, its #61 holding.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Wellington Capital Management's 13F filing for Q2 2025, filed 18 Aug 2025.